免疫系统
生物
病毒学
打开阅读框
病毒
MHC I级
抗原呈递
主要组织相容性复合体
体内
抗原
病毒复制
细胞生物学
免疫学
T细胞
基因
遗传学
肽序列
作者
Yiwen Zhang,Junsong Zhang,Yingshi Chen,Baohong Luo,Yaochang Yuan,Feng Huang,Tao Yang,Fei Yu,Jun Liu,Bing-Fen Liu,Zheng Song,Jingliang Chen,Ting Pan,Xu Zhang,Yuzhuang Li,Rong Li,Wenjing Huang,Fei Xiao,Hui Zhang
标识
DOI:10.1101/2020.05.24.111823
摘要
Summary SARS-CoV-2 infection have caused global pandemic and claimed over 5,000,000 tolls 1–4 . Although the genetic sequences of their etiologic viruses are of high homology, the clinical and pathological characteristics of COVID-19 significantly differ from SARS 5,6 . Especially, it seems that SARS-CoV-2 undergoes vast replication in vivo without being effectively monitored by anti-viral immunity 7 . Here, we show that the viral protein encoded from open reading frame 8 (ORF8) of SARS-CoV-2, which shares the least homology with SARS-CoV among all the viral proteins, can directly interact with MHC-I molecules and significantly down-regulates their surface expression on various cell types. In contrast, ORF8a and ORF8b of SARS-CoV do not exert this function. In the ORF8-expressing cells, MHC-I molecules are selectively target for lysosomal degradation by an autophagy-dependent mechanism. As a result, CTLs inefficiently eliminate the ORF8-expressing cells. Our results demonstrate that ORF8 protein disrupts antigen presentation and reduces the recognition and the elimination of virus-infected cells by CTLs 8 . Therefore, we suggest that the inhibition of ORF8 function could be a strategy to improve the special immune surveillance and accelerate the eradication of SARS-CoV-2 in vivo.
科研通智能强力驱动
Strongly Powered by AbleSci AI